Adma Biologics director sells $213,100 in stock
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ADMA Biologics Inc (ADMA)
ADMA Biologics Inc stock price live, this page displays NASDAQ ADMA stock exchange data. View the ADMA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ADMA Biologics Inc real time stock price chart below.
What Is the ADMA Biologics Inc Stock Price Today?
The ADMA Biologics Inc stock price today is 16.8915.
What Is the Stock Symbol for ADMA Biologics Inc?
The stock symbol for ADMA Biologics Inc is ""ADMA.""
What Stock Exchange Does ADMA Biologics Inc Trade On?
ADMA Biologics Inc is listed and trades on the NASDAQ stock exchange.
Is ADMA Biologics Inc a Good Stock to Buy?
Determining whether ADMA Biologics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADMA quote. (ISIN: US0008991046)
What Is the ADMA Biologics Inc Stock Price Today?
The ADMA Biologics Inc stock price today is 16.8915.
What Is the Stock Symbol for ADMA Biologics Inc?
The stock symbol for ADMA Biologics Inc is ""ADMA.""
What Stock Exchange Does ADMA Biologics Inc Trade On?
ADMA Biologics Inc is listed and trades on the NASDAQ stock exchange.
Is ADMA Biologics Inc a Good Stock to Buy?
Determining whether ADMA Biologics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADMA quote. (ISIN: US0008991046)
NASDAQ
Currency in USD
16.8915
-0.1585(-0.93%)
Real-time Data·
Fair Value
An estimate of a ADMA Biologics Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.8150
17.3300
52 wk Range
10.2100
25.6700
ADMA Scorecard
Full Analysis
Cash flows can sufficiently cover interest payments
Earnings results expected in 14 days
More Info
Fair Value
An estimate of a ADMA Biologics Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.815017.3300
52 wk Range
10.210025.6700
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ADMA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a ADMA Biologics Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
29.4900
Upside
+74.58%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
- Form 8K ADMA Biologics Inc For: 4 June
- Investing.com
- Adma Biologics director sells $213,100 in stock
- Investing.com
- Form 8K ADMA Biologics Inc For: 4 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
ADMA Biologics Inc Company Profile
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
ADMA Biologics Inc Earnings Call Summary for Q1/2025
- Q1 2025 revenue reached $114.8M, up 40% YoY, beating forecasts; stock closed +2.03% but fell 4.49% after hours
- Gross profit hit $61.1M with 53.2% margin; adjusted EBITDA rose 81% YoY to $47.9M; GAAP net income at $26.9M
- FDA approved new production process to boost output; voluntary product withdrawals impacted Q1 revenue by $3.8M
- 2025 guidance: $500M+ revenue, $235M+ adjusted EBITDA; 2026 forecast: $625M revenue, $340M+ adjusted EBITDA
- CEO confident in future growth; analysts maintain bullish outlook with price targets ranging from $20.96 to $32.00
Last Updated: 07/05/2025, 22:28
Read Full TranscriptCompare ADMA to Peers and Sector
Metrics to compare | ADMA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipADMAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.5x | −1.9x | −0.5x | |
PEG Ratio | 0.00 | 0.03 | 0.00 | |
Price/Book | 10.8x | 3.5x | 2.6x | |
Price / LTM Sales | 8.8x | 8.3x | 3.2x | |
Upside (Analyst Target) | 81.8% | 183.0% | 42.7% | |
Fair Value Upside | Unlock | 10.8% | 5.8% | Unlock |
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 29.4900
(+74.58% Upside)
Earnings
Latest Release
May 07, 2025
EPS / Forecast
0.1361 / 0.1467
Revenue / Forecast
114.80M / 112.97M
People Also Watch
FAQ
What Stock Exchange Does ADMA Biologics Inc Trade On?
ADMA Biologics Inc is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for ADMA Biologics Inc?
The stock symbol for ADMA Biologics Inc is "ADMA."
What Is the ADMA Biologics Inc Market Cap?
As of today, ADMA Biologics Inc market cap is 4.02B.
What Is ADMA Biologics Inc's Earnings Per Share (TTM)?
The ADMA Biologics Inc EPS (TTM) is 0.88.
When Is the Next ADMA Biologics Inc Earnings Date?
ADMA Biologics Inc will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is ADMA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has ADMA Biologics Inc Stock Split?
ADMA Biologics Inc has split 0 times.
How Many Employees Does ADMA Biologics Inc Have?
ADMA Biologics Inc has 685 employees.
What is the current trading status of ADMA Biologics Inc (ADMA)?
As of 23 Jul 2025, ADMA Biologics Inc (ADMA) is trading at a price of 16.89, with a previous close of 17.05. The stock has fluctuated within a day range of 16.82 to 17.33, while its 52-week range spans from 10.21 to 25.67.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.